The company's customer wins this year suggest more revenue expansion to come. In fact, C3.ai forecasts fiscal 2026 sales to ...

This has led to strong growth for the company, with C3.ai's revenue rising 25% year over year in fourth-quarter fiscal year 2025 (ending April 30). It also expects strong growth for FY 2026, with ...

Upgrade your portfolio! C3.ai is a strong buy with explosive growth, top-tier partnerships, and AI exposure at a discount.

McLaren did not waste any time in stamping its authority on the Hungarian Grand Prix weekend. Lando Norris and Oscar Piastri, ...

Four astronauts are on their way to the International Space Station after being sidelined by Boeing's Starliner trouble and ...

Alpha Dhabi’s sustained focus on capturing strategic opportunities and continued momentum in executing its strategy across key verticals is evident in the strong financial performance, with group ...

Apellis Pharmaceuticals Inc. (NASDAQ:APLS) is one of the biotech stocks to buy according to Wall Street analysts.

U.S. kindergarten vaccination rates inched down again last year and the proportion of children with exemptions rose to an all ...

Grange Fair, Bellefonte Arts & Crafts Fair and Penn State Ag Progress Days are among the biggest headliners in August.

Huntington Ingalls Industries, America’s largest military shipbuilder and a global defense technology provider, announced its ...

The Hungaroring provides the backdrop to the last few days of Formula 1 track action prior to the summer break. This weekend’s race will be the fortieth anniv ...

Segment operating income2 in the second quarter of 2025 was $172 million and segment operating margin2 was 5.6%, compared to $203 million and 6.8%, respectively, in the second quarter of 2024. The ...